Curative Conversion of Metastatic Gastric Cancer After Pembrolizumab-Trastuzumab-Based Therapy in a PD-L1-Negative, HER2-Positive Patient: A Case Report and Literature Review. (2026). MENA Journal of Case Reports, 1(1), 30-38. https://doi.org/10.64913/mmrmjcr.v1i1.21